INCYTE CORPORATION Cost of Goods Sold (Deprecated 2018-01-31)
INCYTE CORPORATION (INCY) reported Cost of Goods Sold (Deprecated 2018-01-31) of $79.48 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-15.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-02-15
- INCYTE CORPORATION cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $22.36M, a 14.02% increase year-over-year.
- INCYTE CORPORATION cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $22.04M, a 9.06% increase year-over-year.
- INCYTE CORPORATION cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $20.26M, a 63.82% increase year-over-year.
- INCYTE CORPORATION cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $14.82M, a 146.86% increase year-over-year.
- INCYTE CORPORATION cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $79.48M, a 36.59% increase from fiscal 2016.
- INCYTE CORPORATION cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $58.19M, a 115.73% increase from fiscal 2015.
- INCYTE CORPORATION cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $26.97M, a 797.87% increase from fiscal 2014.
- INCYTE CORPORATION cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $3.00M, a 376.83% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $22.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $44.40M derived: sum of 2 quarters · filed 2018-02-15 | $64.66M derived: sum of 3 quarters · filed 2018-02-15 | $79.48M 10-K · filed 2018-02-15 |
| 2017-09-30 | $22.04M 10-Q · filed 2017-10-31 | $42.30M derived: sum of 2 quarters · filed 2017-10-31 | $57.12M 10-Q · filed 2017-10-31 | $76.73M derived: sum of 4 quarters · filed 2018-02-15 |
| 2017-06-30 | $20.26M 10-Q · filed 2017-08-01 | $35.08M 10-Q · filed 2017-08-01 | $54.69M derived: sum of 3 quarters · filed 2018-02-15 | $74.90M derived: sum of 4 quarters · filed 2018-02-15 |
| 2017-03-31 | $14.82M 10-Q · filed 2017-05-04 | $34.43M derived: sum of 2 quarters · filed 2018-02-15 | $54.64M derived: sum of 3 quarters · filed 2018-02-15 | $67.01M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-12-31 | $19.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $39.81M derived: sum of 2 quarters · filed 2018-02-15 | $52.18M derived: sum of 3 quarters · filed 2018-02-15 | $58.19M 10-K · filed 2018-02-15 |
| 2016-09-30 | $20.20M 10-Q · filed 2017-10-31 | $32.57M derived: sum of 2 quarters · filed 2017-10-31 | $38.58M 10-Q · filed 2017-10-31 | $48.28M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $12.37M 10-Q · filed 2017-08-01 | $18.37M 10-Q · filed 2017-08-01 | $28.08M derived: sum of 3 quarters · filed 2018-02-15 | $36.12M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $6.00M 10-Q · filed 2017-05-04 | $15.71M derived: sum of 2 quarters · filed 2018-02-15 | $23.75M derived: sum of 3 quarters · filed 2018-02-15 | $30.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $17.74M derived: sum of 2 quarters · filed 2018-02-15 | $24.00M derived: sum of 3 quarters · filed 2018-02-15 | $26.97M 10-K · filed 2018-02-15 |
| 2015-09-30 | $8.04M 10-Q · filed 2016-11-01 | $14.29M derived: sum of 2 quarters · filed 2016-11-01 | $17.27M 10-Q · filed 2016-11-01 | $19.70M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $6.25M 10-Q · filed 2016-08-09 | $9.23M 10-Q · filed 2016-08-09 | $11.66M derived: sum of 3 quarters · filed 2017-02-14 | $11.88M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $2.97M 10-Q · filed 2016-05-09 | $5.40M derived: sum of 2 quarters · filed 2017-02-14 | $5.62M derived: sum of 3 quarters · filed 2017-02-14 | $5.81M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $2.65M derived: sum of 2 quarters · filed 2017-02-14 | $2.84M derived: sum of 3 quarters · filed 2017-02-14 | $3.00M 10-K · filed 2017-02-14 |
| 2014-09-30 | $221.00K 10-Q · filed 2015-11-03 | $408.00K derived: sum of 2 quarters · filed 2015-11-03 | $576.00K 10-Q · filed 2015-11-03 | $743.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $187.00K 10-Q · filed 2015-08-04 | $355.00K 10-Q · filed 2015-08-04 | $522.00K derived: sum of 3 quarters · filed 2016-02-12 | $677.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $168.00K 10-Q · filed 2015-04-30 | $335.00K derived: sum of 2 quarters · filed 2016-02-12 | $490.00K derived: sum of 3 quarters · filed 2016-02-12 | $647.00K derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $322.00K derived: sum of 2 quarters · filed 2016-02-12 | $479.00K derived: sum of 3 quarters · filed 2016-02-12 | $630.00K 10-K · filed 2016-02-12 |
| 2013-09-30 | $155.00K 10-Q · filed 2014-10-30 | $312.00K derived: sum of 2 quarters · filed 2014-10-30 | $463.00K 10-Q · filed 2014-10-30 | $561.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $157.00K 10-Q · filed 2014-07-31 | $308.00K 10-Q · filed 2014-07-31 | $406.00K derived: sum of 3 quarters · filed 2015-02-17 | $437.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $150.00K 10-Q · filed 2014-05-01 | $249.00K derived: sum of 2 quarters · filed 2015-02-17 | $280.00K derived: sum of 3 quarters · filed 2015-02-17 | $296.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $130.00K derived: sum of 2 quarters · filed 2015-02-17 | $146.00K derived: sum of 3 quarters · filed 2015-02-17 | $157.00K 10-K · filed 2015-02-17 |
| 2012-09-30 | $31.00K 10-Q · filed 2013-10-31 | $47.00K derived: sum of 2 quarters · filed 2013-10-31 | $58.00K 10-Q · filed 2013-10-31 | |
| 2012-06-30 | $16.00K 10-Q · filed 2013-08-01 | $27.00K 10-Q · filed 2013-08-01 | ||
| 2012-03-31 | $11.00K 10-Q · filed 2013-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |